Review Article
Efficacy and Safety of Nivolumab for Advanced Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Table 2
Quality assessment of the eligible literature.
| | Eligible study | Randomization | Allocation concealment | Blinding | Withdrawal | ITT analysis | Baseline features | Quality level |
| | Choueiri et al. | Stratified randomization | Unclear | Open-label | Yes | Yes | Similar | B | | Motzer et al. | Stratified randomization | Yes | Open-label | Yes | Yes | Similar | A | | Albiges et al. | Stratified randomization | Yes | Open-label | Yes | Yes | Similar | A |
|
|
ITT, intention-to-treat.
|
